Coya Therapeutics (COYA) Earnings Date & Reports

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs)... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

COYA is expected to report earnings to rise 153.57% to -70 cents per share on November 11

Coya Therapeutics COYA Stock Earnings Reports

Q3'26

Est.

$-0.71

Q2'26

Beat

by $0.42

Q1'26

Beat

by $0.37

Q4'25

Beat

by $0.31

Q3'25

Beat

by $0.46

The last earnings report on August 11 showed earnings per share of -28 cents, beating the estimate of -69 cents. With 41.49K shares outstanding, the current market capitalization sits at 116.82M.

View a ticker or compare two or three

COYA

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for COYA